{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:11:21Z","timestamp":1787062281826,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T00:00:00Z","timestamp":1601683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T00:00:00Z","timestamp":1601683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100014480","name":"Horizon Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30AR072581"],"award-info":[{"award-number":["P30AR072581"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002529"],"award-info":[{"award-number":["UL1TR002529"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Radiol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00256-020-03625-3","type":"journal-article","created":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T01:02:41Z","timestamp":1601686961000},"page":"903-913","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Radiographic imaging, densitometry and disease severity in Autosomal dominant osteopetrosis type 2"],"prefix":"10.1007","volume":"50","author":[{"given":"Lauren M.","family":"Ladd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik A.","family":"Imel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Niziolek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Warden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Econs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,3]]},"reference":[{"key":"3625_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bone.2017.02.002","volume":"102","author":"A Teti","year":"2017","unstructured":"Teti A, Econs MJ. Osteopetroses, emphasizing potential approaches to treatment. Bone. 2017;102:50\u20139.","journal-title":"Bone."},{"key":"3625_CR2","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrendo.2013.137","volume":"9","author":"C Sobacchi","year":"2013","unstructured":"Sobacchi C, Schulz A, Coxon F, Villa A, Helfrich M. Osteopetrosis: genetics, treatment, and new insights into osteoclast function. Nat Rev Endocrinol. 2013;9:522\u201336.","journal-title":"Nat Rev Endocrinol"},{"key":"3625_CR3","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1530\/EJE-13-0136","volume":"169","author":"J Bollerslev","year":"2013","unstructured":"Bollerslev J, Henriksen K, Nielsen MF, Brixen K, Hul WV. Autosomal dominant osteopetrosis revisited: lessons from recent studies. Eur J Endocrinol. 2013;169:R39\u201357.","journal-title":"Eur J Endocrinol"},{"key":"3625_CR4","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1210\/jc.2006-1986","volume":"92","author":"SG Waguespack","year":"2007","unstructured":"Waguespack SG, Hui SL, DiMeglio LA, Econs MJ. Autosomal Dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation. J Clin Endocrinol Metab. 2007;92:771\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"3625_CR5","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1093\/hmg\/10.25.2861","volume":"10","author":"E Cleiren","year":"2001","unstructured":"Cleiren E, B\u00e9nichou O, Van Hul E, Gram J, Bollerslev J, Singer FR, et al. Albers-Sch\u00f6nberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet. 2001;10:2861\u20137.","journal-title":"Hum Mol Genet"},{"key":"3625_CR6","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1359\/jbmr.060409","volume":"21","author":"K Chu","year":"2006","unstructured":"Chu K, Snyder R, Econs MJ. Disease status in autosomal dominant osteopetrosis type 2 Is determined by osteoclastic properties. J Bone Miner Res. 2006;21:1089\u201397.","journal-title":"J Bone Miner Res"},{"key":"3625_CR7","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/S0002-9440(10)63712-1","volume":"164","author":"K Henriksen","year":"2004","unstructured":"Henriksen K, Gram J, Schaller S, Dahl BH, Dziegiel MH, Bollerslev J, et al. Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II. Am J Pathol. 2004;164:1537\u201345.","journal-title":"Am J Pathol"},{"key":"3625_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/jmg.2005.036673","volume":"43","author":"A Del Fattore","year":"2005","unstructured":"Del Fattore A. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet. 2005;43:315\u201325.","journal-title":"J Med Genet"},{"key":"3625_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1750-1172-4-5","volume":"4","author":"Z Stark","year":"2009","unstructured":"Stark Z, Savarirayan R. Osteopetrosis. Orphanet J Rare Dis. 2009;4:5.","journal-title":"Orphanet J Rare Dis"},{"key":"3625_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/00005792-196803000-00004","volume":"47","author":"CC Johnston","year":"1968","unstructured":"Johnston CC, Lavy N, Lord T, Vellios F, Merritt AD, Deiss WP. Osteopetrosis. A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form. Medicine (Baltimore). 1968;47:149\u201367.","journal-title":"Medicine (Baltimore)"},{"key":"3625_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S8756-3282(99)00244-6","volume":"26","author":"OD Benichou","year":"2000","unstructured":"Benichou OD, Laredo JD, De Vernejoul MC. Type II autosomal dominant osteopetrosis (Albers-Sch\u00f6nberg disease): clinical and radiological manifestations in 42 patients. Bone. 2000;26:87\u201393.","journal-title":"Bone."},{"key":"3625_CR12","first-page":"1","volume":"2013","author":"P Kant","year":"2013","unstructured":"Kant P, Sharda N, Bhowate RR. Clinical and radiological findings of autosomal dominant osteopetrosis type II: a case report. Case Rep Dent. 2013;2013:1\u20138.","journal-title":"Case Rep Dent"},{"key":"3625_CR13","first-page":"431","volume":"16","author":"E Grodum","year":"1995","unstructured":"Grodum E, Gram J, Brixen K, Bollerslev J. Autosomal dominant osteopetrosis: bone mineral measurements of the entire skeleton of adults in two different subtypes. Bone. 1995;16:431\u20134.","journal-title":"Bone."},{"key":"3625_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0009-9260(03)00337-4","volume":"59","author":"HJ Williams","year":"2004","unstructured":"Williams HJ, Davies AM, Chapman S. Bone within a bone. Clin Radiol. 2004;59:132\u201344.","journal-title":"Clin Radiol"},{"key":"3625_CR15","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/rheumatology\/ket007","volume":"52","author":"CL Gregson","year":"2013","unstructured":"Gregson CL, Hardcastle SA, Cooper C, Tobias JH. Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management. Rheumatology. 2013;52:968\u201385.","journal-title":"Rheumatology."},{"key":"3625_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/pch\/11.1.37","volume":"11","author":"A-LH Hamdan","year":"2006","unstructured":"Hamdan A-LH, Nabulsi MM, Farhat FT, Haidar RK, Fuleihan NS. When bone becomes marble: head and neck manifestations of osteopetrosis. Paediatr Child Health. 2006;11:37\u201340.","journal-title":"Paediatr Child Health"},{"key":"3625_CR17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/jbmr.2715","volume":"31","author":"M Arruda","year":"2016","unstructured":"Arruda M, Coelho MCA, Moraes AB, de Paula Paranhos-Neto F, Madeira M, Farias MLF, et al. Bone mineral density and microarchitecture in patients with autosomal dominant osteopetrosis: a report of two cases. J Bone Miner Res. 2016;31:657\u201362.","journal-title":"J Bone Miner Res"},{"key":"3625_CR18","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1002\/jbmr.3715","volume":"34","author":"EA Imel","year":"2019","unstructured":"Imel EA, Liu Z, Acton D, Coffman M, Gebregziabher N, Tong Y, et al. Interferon gamma-1b does not increase markers of bone resorption in autosomal dominant osteopetrosis. J Bone Miner Res. 2019;34:1436\u201345.","journal-title":"J Bone Miner Res"},{"key":"3625_CR19","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2214\/AJR.10.5416","volume":"196","author":"R Lorente-Ramos","year":"2011","unstructured":"Lorente-Ramos R, Azpeitia-Arm\u00e1n J, Mu\u00f1oz-Hern\u00e1ndez A, Garc\u00eda-G\u00f3mez JM, D\u00edez-Mart\u00ednez P, Grande-B\u00e1rez M. Dual-energy X-ray absorptiometry in the diagnosis of osteoporosis: a practical guide. Am J Roentgenol. 2011;196:897\u2013904.","journal-title":"Am J Roentgenol"},{"key":"3625_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00223-015-0078-2","volume":"98","author":"AM Weatherholt","year":"2016","unstructured":"Weatherholt AM, Warden SJ. Tibial bone strength is enhanced in the jump leg of collegiate-level jumping athletes: a within-subject controlled cross-sectional study. Calcif Tissue Int. 2016;98:129\u201339.","journal-title":"Calcif Tissue Int"},{"key":"3625_CR21","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s00198-009-1151-3","volume":"21","author":"RR Swinford","year":"2010","unstructured":"Swinford RR, Warden SJ. Factors affecting short-term precision of musculoskeletal measures using peripheral quantitative computed tomography (pQCT). Osteoporos Int. 2010;21:1863\u201370.","journal-title":"Osteoporos Int"},{"key":"3625_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/8756-3282(85)90399-0","volume":"6","author":"CE Cann","year":"1985","unstructured":"Cann CE, Genant HK, Kolb FO, Ettinger B. Quantitative computed tomography for prediction of vertebral fracture risk. Bone. 1985;6:1\u20137.","journal-title":"Bone."},{"key":"3625_CR23","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00198-008-0820-y","volume":"20","author":"BCC Khoo","year":"2009","unstructured":"Khoo BCC, Brown K, Cann C, Zhu K, Henzell S, Low V, et al. Comparison of QCT-derived and DXA-derived areal bone mineral density and T scores. Osteoporos Int. 2009;20:1539\u201345.","journal-title":"Osteoporos Int"},{"key":"3625_CR24","first-page":"1","volume":"2013","author":"N Li","year":"2013","unstructured":"Li N, Li X, Xu L, Sun W, Cheng X, Tian W. Comparison of QCT and DXA: osteoporosis detection rates in postmenopausal women. Int J Endocrinol. 2013;2013:1\u20135.","journal-title":"Int J Endocrinol"},{"key":"3625_CR25","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jocd.2014.04.119","volume":"17","author":"TM Link","year":"2014","unstructured":"Link TM, Lang TF. Axial QCT: clinical applications and new developments. J Clin Densitom Off J Int Soc Clin Densitom. 2014;17:438\u201348.","journal-title":"J Clin Densitom Off J Int Soc Clin Densitom"},{"key":"3625_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/jbmr.5650040218","volume":"4","author":"JE Block","year":"1989","unstructured":"Block JE, Smith R, Glueer C-C, Steiger P, Ettinger B, Genant HK. Models of spinal trabecular bone loss as determined by quantitative computed tomography. J Bone Miner Res. 1989;4:249\u201357.","journal-title":"J Bone Miner Res"},{"key":"3625_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000489672","volume":"47","author":"SM Ott","year":"2018","unstructured":"Ott SM. Cortical or trabecular bone: what\u2019s the difference? Am J Nephrol. 2018;47:373\u20135.","journal-title":"Am J Nephrol"},{"key":"3625_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/0972-3919.147544","volume":"30","author":"C Sit","year":"2015","unstructured":"Sit C, Agrawal K, Fogelman I, Gnanasegaran G. Osteopetrosis: Radiological & radionuclide imaging. Indian J Nucl Med. 2015;30:55.","journal-title":"Indian J Nucl Med"},{"key":"3625_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/13697130801959590","volume":"11","author":"T Iizuka","year":"2008","unstructured":"Iizuka T, Matsukawa M. Potential excessive suppression of bone turnover with long-term oral bisphosphonate therapy in postmenopausal osteoporotic patients. Climacteric. 2008;11:287\u201395.","journal-title":"Climacteric."},{"key":"3625_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bone.2016.10.016","volume":"94","author":"I Alam","year":"2017","unstructured":"Alam I, McQueen AK, Acton D, Reilly AM, Gerard-O\u2019Riley RL, Oakes DK, et al. Phenotypic severity of autosomal dominant osteopetrosis type II (ADO2) mice on different genetic backgrounds recapitulates the features of human disease. Bone. 2017;94:34\u201341.","journal-title":"Bone."},{"key":"3625_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF00361862","volume":"7","author":"L Krook","year":"1981","unstructured":"Krook L, Whalen JP, Dorfman HD, Norman A, Nunez EA. Osteopetrosis: an interpretation of its pathogenesis. Skelet Radiol. 1981;7:185\u20139.","journal-title":"Skelet Radiol"}],"container-title":["Skeletal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00256-020-03625-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00256-020-03625-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00256-020-03625-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T16:12:37Z","timestamp":1633363957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00256-020-03625-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,3]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["3625"],"URL":"https:\/\/doi.org\/10.1007\/s00256-020-03625-3","relation":{},"ISSN":["0364-2348","1432-2161"],"issn-type":[{"value":"0364-2348","type":"print"},{"value":"1432-2161","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,3]]},"assertion":[{"value":"24 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no other\u00a0conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or Horizon Pharmaceuticals.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}